BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)
Investigation Announcements: Brodsky & Smith is reminding investors about ongoing investigations into several companies, including Verve Therapeutics, Sage Therapeutics, Cantaloupe, and Volato Group, regarding potential breaches of fiduciary duties by their boards during acquisition processes.
Acquisition Details: Each company is set to be acquired at specified cash prices per share, with additional contingent value rights, raising concerns about whether these deals provide fair value to shareholders.
Discover Tomorrow's Bullish Stocks Today
Analyst Views on CTLP
About CTLP
About the author
Significant Options Trading on Thursday: SNOW, CTLP, AMR
Cantaloupe Inc Options Activity: Cantaloupe Inc (CTLP) has seen a trading volume of 4,353 options contracts today, equating to about 62.6% of its average daily trading volume, with significant activity in the $7.50 strike put option expiring January 15, 2027.
Alpha Metallurgical Resources Options Activity: Alpha Metallurgical Resources Inc (AMR) recorded a trading volume of 1,695 options contracts, representing approximately 60.6% of its average daily trading volume, with notable trading in the $220 strike call option expiring January 16, 2026.
Options Trading Insights: The article provides insights into the options trading activities of CTLP and AMR, highlighting specific strike prices and expiration dates that have garnered high volumes.
Disclaimer: The views expressed in the article are those of the author and do not necessarily reflect the opinions of Nasdaq, Inc.
OppFi Surges 33% Year-to-Date: Is It Still a Good Time to Buy the Stock?
Stock Performance: OppFi Inc. (OPFI) has seen a 32.5% increase in shares year-to-date, outperforming its industry and notable competitors like Cantaloupe and Fidelity National Information Services.
Operational Efficiency: The company's AI and machine learning-based Model 6 improved auto approval rates and significantly reduced expenses, leading to a 136.9% increase in net income year-over-year.
Positive Guidance: OppFi has consistently raised its guidance for adjusted net income and earnings per share for 2025, reflecting strong investor confidence in its profitability.
Valuation Appeal: OPFI is currently undervalued compared to its industry, with lower forward earnings and EV-to-EBITDA ratios, making it an attractive option for value-based investors.
